Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Incrocci

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Histopathology|November 3, 2017
Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7Esther I Verhoef, Charlotte F Kweldam, Intan P Kümmerlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2008
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancerAbrahim Al-Mamgani, Wim L J van Putten, Wilma D Heemsbergen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2017
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancerCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
The Lancet. Oncology|February 7, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Annals of Surgery|December 19, 2008
Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trialMarjolein J M Morak, Ate van der Gaast, Luca Incrocci, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markersGerard J van der Wielen, Theodore F Mutanga, Luca Incrocci, et al.
Frontiers in Oncology|June 19, 2025
A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective studyAbba Mallum, Maureen Bilinga Tendwa, Rakiya Saidu, et al.
Archives of Pathology & Laboratory Medicine|January 7, 2020
Comparison of Tumor Volume Parameters on Prostate Cancer BiopsiesEsther I Verhoef, Charlotte F Kweldam, Intan P Kümmerlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 GyStephanie T H Peeters, Wilma D Heemsbergen, Peter C M Koper, et al.
Frontiers in Plant Science|October 16, 2019
Salinity in Autumn-Winter Season and Fruit Quality of Tomato LandracesTommaso Michele Moles, Rita de Brito Francisco, Lorenzo Mariotti, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Histopathology|November 3, 2017
Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7Esther I Verhoef, Charlotte F Kweldam, Intan P Kümmerlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2008
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancerAbrahim Al-Mamgani, Wim L J van Putten, Wilma D Heemsbergen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 23, 2017
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancerCharlotte F Kweldam, Intan P Kümmerlin, Daan Nieboer, et al.
The Lancet. Oncology|February 7, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Annals of Surgery|December 19, 2008
Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trialMarjolein J M Morak, Ate van der Gaast, Luca Incrocci, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markersGerard J van der Wielen, Theodore F Mutanga, Luca Incrocci, et al.
Frontiers in Oncology|June 19, 2025
A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective studyAbba Mallum, Maureen Bilinga Tendwa, Rakiya Saidu, et al.
Archives of Pathology & Laboratory Medicine|January 7, 2020
Comparison of Tumor Volume Parameters on Prostate Cancer BiopsiesEsther I Verhoef, Charlotte F Kweldam, Intan P Kümmerlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 GyStephanie T H Peeters, Wilma D Heemsbergen, Peter C M Koper, et al.
Frontiers in Plant Science|October 16, 2019
Salinity in Autumn-Winter Season and Fruit Quality of Tomato LandracesTommaso Michele Moles, Rita de Brito Francisco, Lorenzo Mariotti, et al.
Pageof 15